Development of software for data analysis by therapeutic drug monitoring of teicoplanin, a glycopeptide antibiotic

Japanese Journal of Antibiotics

Volumn 57, Issue 4, 2004, Pages 413-419

  Niwa, Toshiro ^a   Tokuma, Yoji ^a   Ito, Takao ^a   Kimura, Jiro ^a   Tabata, Kenji ^a   Takagi, Akira ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TEICOPLANIN;

ALGORITHM; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CREATININE CLEARANCE; DATA ANALYSIS; DRUG MONITORING; HUMAN; MICROCOMPUTER; MULTIPLE REGRESSION; PREDICTION;

ADULT; ANTI-BACTERIAL AGENTS; BAYES THEOREM; CREATININE; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; HUMANS; MALE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; SOFTWARE DESIGN; STATISTICS; TEICOPLANIN;

EID: 4544292701     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. BONATI, M.; G. L. TRAINA, G. VILLA, et al.: Teicoplanin pharmacokinetics in patients with chronic renal failure. Clin. Pharmacokinet. 12: 292-301, 1987
2. YAMAOKA, K.; T. NAKAGAWA, H. TANAKA, et al.: A nonlinear multiple regression program MULTI2 (BAYES), based on Bayesian algorithm for microcomputers. J. Pharmacobio-Dyn. 8: 246-256, 1985
3. ROWLAND, M.: Clinical pharmacokinetics of teicoplanin. Clin. Pharmacokinet. 18: 184-209, 1990
4. COCKCROFT, D. W. & M. H. GAULT: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976